Factors Associated With Hypoventilation in the Myotonic Dystrophy, Progressive Profile Over 5 Years
NCT ID: NCT03764150
Last Updated: 2025-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
113 participants
OBSERVATIONAL
2010-06-30
2023-06-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postural Spirometry Changes in Ambulatory Myotonic Dystrophy Patients
NCT01242007
Natural History of Cardiac and Respiration Function in Patients With Muscular Dystrophies on Home Mechanical Ventilation
NCT02501083
Study of the Correlation Between Muscle Oxygenation and Motor Function in Children With Neuromuscular Disease.
NCT03471676
Muscle Oxygenation in Effort in Neuromuscular Diseases
NCT02789059
Regional Distribution of Ventilation to Assess Respiratory Muscle Dysfunction
NCT01569217
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PaCO2> 45 mmHg
Diurnal hypercapnia defined by PaCO2\> 45 mmHg
No interventions assigned to this group
PaCO2 <45 mmHg
PaCO2 diurnal within the limits of normal (PaCO2 \<45 mmHg)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Moderate to severe asthma according to the GINA classification
* moderate to severe COPD (\> stage 1 of the GOLD recommendations)
* Other significant respiratory pathology
* Patient already on NIV, CPAP or under oxygen therapy
* Impossibility of receiving enlightened information
* Inability to participate in the entire study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thierry Perez, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Regional D' Angers
Angers, , France
Ap-Hp Hu Paris Site Raymond Poincare
Garches, , France
Hôpital Calmette, CHRU
Lille, , France
Chu Montpellier
Montpellier, , France
Chu de Nantes :Site Hôtel-Dieu- Hme - Nantes 1
Nantes, , France
Ap-Hp Hu Pitie Salpetriere
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009-A00588-49
Identifier Type: OTHER
Identifier Source: secondary_id
2009_04/0923
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.